What 37 Years in Respiratory Healthcare Looks Like: The Story Behind Rezibase and Cardiobase
Rezibase is a cloud-based respiratory and sleep reporting platform built by respiratory scientists, for respiratory scientists. Born from 37 years of combined clinical experience, it was designed to solve the real, daily frustrations of clinical physiology labs: clunky legacy software, vendor lock-in, and systems that never quite fit how labs actually work. Today, it is trusted by over 35 sites across Australia and the UK, including the NHS and NSW Health, and is recognised as Australia's most advanced respiratory and sleep solution.
TL;DR
Rezibase was founded by respiratory scientists Peter Rochford and the late Jeff Pretto, built on decades of firsthand clinical experience.
The platform was acquired by Cardiobase, which brought the engineering capability to move it to a robust, enterprise-grade cloud.
It covers both respiratory and sleep, is fully vendor-neutral, and integrates with major hospital systems.
Rezibase operates without lock-in contracts, offers a 30-day free trial, and uses transparent monthly pricing.
With clients in Australia, New Zealand, the UK, and Ireland, including the NHS, Rezibase is built to last.
About the Author: This article was written by the Rezibase team, drawing on over 37 years of direct experience in respiratory and sleep healthcare technology and clinical physiology lab operations across Australia, New Zealand, the UK, and Ireland.
Why does the "who built it" question matter so much in healthcare software?
In most industries, software is built by engineers who study a market. In healthcare, that gap between builder and user creates real consequences: workflows that don't match how clinicians think, reporting tools that ignore established guidelines, and systems that require users to adapt to the software rather than the other way around.
Rezibase is different because it was designed from the inside. Founded by respiratory scientists Peter Rochford and the late Jeff Pretto, the platform emerged from direct clinical experience, not from a product roadmap built around market opportunity. That distinction matters because the frustrations it solves, such as double data entry, manual calculations, outdated normal values, and the absence of ATS-compliant reporting, are frustrations that its founders lived [Cardiobase].
When software is shaped by the people who use it daily, the result is a product that fits clinical reality rather than fighting it.
What is the story behind Rezibase and Cardiobase?
Rezibase began as a purpose-built reporting system developed to fill a genuine gap in respiratory and sleep lab management. Over eight years, it was refined by respiratory scientists who understood precisely what clinical physiology labs needed and what existing solutions consistently failed to deliver [Cardiobase].
The turning point came when Rezibase joined forces with Cardiobase, a healthcare technology company with deep engineering capability and a shared philosophy: solve real problems, avoid over-complication, and always put the customer first. That partnership brought three things the platform needed to grow:
The technical infrastructure to move Rezibase to a secure, enterprise-grade cloud environment.
The capacity to expand beyond its original footprint into new markets, including the NHS in the UK.
A long-term commitment to ongoing development, compliance, and support.
The result is a platform that carries 37 years of respiratory healthcare knowledge and pairs it with modern software architecture. That combination is rare, and it is central to what makes Rezibase credible.
What makes Rezibase different from other respiratory lab software?
The respiratory software market has options, but most of them share a common limitation: they are built by device manufacturers or generalist software companies, which means they tend to favour their own hardware or apply generic clinical workflows to a highly specialised environment.
Rezibase takes a different position on several fronts:
Differentiator | What it means in practice |
|---|---|
Vendor-neutral | Import data from any device, from any manufacturer, with no restrictions |
Built by scientists | Workflows reflect how labs actually operate, not how vendors assume they do |
Covers respiratory and sleep | One platform, not two separate systems stitched together |
Cloud-based SaaS | No servers to manage, no local IT overhead, accessible from anywhere |
No lock-in contracts | Month-to-month pricing with a 30-day free trial |
Enterprise-grade | Can also be deployed on-premise for hospitals with specific infrastructure requirements |
The Magic Import feature is a practical example of this philosophy. Rather than requiring labs to manually re-enter device data, it directly imports device reports and automatically extracts discrete data, including flow-volume loops. It removes a step that should never have existed in the first place.
How does Rezibase support accreditation and compliance?
Accreditation is one of the most time-consuming operational burdens for respiratory and sleep labs. Rezibase includes a dedicated accreditation module built specifically to support TSANZ and NATA standards, including ISO 15189 requirements.
Key features within the accreditation module include:
Document management
Training records and tracking
Non-conformance reporting
Action plans
Audits
Quality Control managed according to Westgard methods
This is not a bolt-on feature. It is integrated into the platform because accreditation is part of how labs operate, not an annual exercise separate from daily work.
On the clinical side, the platform's normal values library is pre-configured and regularly updated, and its reporting tools are structured around ATS guidelines. Intelligent, AI-powered report writing assists doctors in producing structured, compliant reports without adding steps to their workflow. By 2025, an estimated 75% of respiratory devices were expected to have intelligent capabilities [Future Trends in Respiratory Care Manufacturing], and Rezibase's approach to AI-assisted reporting reflects that direction without overstating what the technology does.
What does switching to Rezibase actually involve?
Moving to a new clinical system can feel daunting, but the transition to Rezibase is designed to be straightforward. The platform's cloud-based nature means there is no server installation, no local deployment complexity, and no IT project to manage before you can get started.
For labs moving from another system, including previous Respiro users, the data migration process is handled with support from the Rezibase team. The goal is to ensure continuity, not disruption. Because Rezibase integrates with Patient Administration Systems, EMR systems, DICOM Modality Worklists, and hospital finance and ordering systems, it fits into existing hospital infrastructure rather than requiring labs to rebuild around it.
The 30-day free trial means teams can explore the platform in their own environment before making any commitment.
Frequently Asked Questions
Who built Rezibase?
Rezibase was founded by respiratory scientists Peter Rochford and the late Jeff Pretto, developed over eight years to address real gaps in clinical physiology lab software [Cardiobase].
Is Rezibase only for respiratory labs?
No. Rezibase covers both respiratory and sleep, making it a single platform for labs that manage both functions.
Does Rezibase work with all device brands?
Yes. Rezibase is fully vendor-neutral, meaning it supports data import from any device manufacturer without restriction.
Is Rezibase available outside Australia?
Yes. Rezibase is currently used across Australia, New Zealand, the UK (including the NHS), and Ireland.
What happens to existing data when switching to Rezibase?
Data migration is supported by the Rezibase team and is designed to be a smooth process with continuity as the priority.
Is there a contract required?
No. Rezibase operates on a transparent monthly pricing model with no lock-in contracts and includes a 30-day free trial.
Can Rezibase be deployed on-premise?
Yes. While Rezibase is primarily a cloud-based SaaS platform, it can also be deployed on-premise for hospitals with specific infrastructure requirements.
About Rezibase
Rezibase is Australia's most advanced respiratory and sleep reporting platform, trusted by over 35 sites including the NHS and NSW Health. Built by respiratory scientists and supported by Cardiobase's healthcare technology expertise, it delivers a vendor-neutral, cloud-based solution that covers the full clinical and administrative lifecycle of respiratory and sleep labs. Rezibase's mission is straightforward: improve patient care using technology, by making life easier for the scientists who deliver it.
Ready to see what 37 years of respiratory expertise looks like in a modern platform? Visit rezibase.com to start your free 30-day trial or speak with the team.